Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: margie who wrote (4126)	4/22/1998 10:44:00 AM
From: Bhag Karamchandani	Read Replies (1) \| Respond to of 6136

SHORT INTEREST RATIO ( SHORT SHARES/ AVERAGE DAILY VOLUME) 3/98 7,714,800 14.27 2/98 8,820,460 13.56 Although the number of 'short' shares has declined, the covering ratio has slightly increased suggesting a better price improvement potential if (or is it when??) the shorts require cover. Fundamentally, AGPH appears to be an underpriced stock - it should appeal to value investors but I suppose these guys don't buy biotechs. Any news on insider buying rather than selling would be interesting.